Literature DB >> 16004838

The management of opioid-related sedation.

Lauren Shaiova1.   

Abstract

There are many side effects of opioids used for cancer and non-cancer pain, which can limit their use and vastly undermine the quality of life for patients. Sedation is a frequent and serious side effect of opioid analgesics, sometimes reported as fatigue or tiredness from patients. There are a number of specific therapies to control or manage these adverse effects, making it feasible to dose opioids to adequate analgesia with tolerable side effects. The balance between effect and side effects is the goal of chronic opioid pharmacotherapy. In particular, sedation commonly can be problematic in a patient who is taking opioids, to the extent that one may want to discontinue the medication and suffer with the pain rather than experience debilitating fatigue or sedation. When sedation clinically becomes excessive, measures should be taken to make it possible to continue treatment with analgesics with acceptable sedation management. There are many techniques to oppose sedation including simple antidotes, such as rest, exercise, and timing of opioid medications, and more complex solutions, such as opioid rotation and the use of psychostimulants or other classes of medications to counteract sedation. The treatment of opioid-induced sedation can be very effective and should be part of a skill set that the clinician can easily employ to enhance the quality of life of patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16004838     DOI: 10.1007/s11916-005-0030-7

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  20 in total

1.  Side-effects of opioids in chronic pain treatment.

Authors:  P G Lawlor; E Bruera
Journal:  Curr Opin Anaesthesiol       Date:  1998-10       Impact factor: 2.706

Review 2.  Fatigue in cancer patients: a review of the literature.

Authors:  A Richardson
Journal:  Eur J Cancer Care (Engl)       Date:  1995-03       Impact factor: 2.520

3.  A qualitative study to explore the concept of fatigue/tiredness in cancer patients and in healthy individuals.

Authors:  A Glaus; R Crow; S Hammond
Journal:  Support Care Cancer       Date:  1996-03       Impact factor: 3.603

4.  Symptoms during cancer pain treatment following WHO-guidelines: a longitudinal follow-up study of symptom prevalence, severity and etiology.

Authors:  T Meuser; C Pietruck; L Radbruch; P Stute; K A Lehmann; S Grond
Journal:  Pain       Date:  2001-09       Impact factor: 6.961

5.  Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain.

Authors:  Miguel Angel Benítez-Rosario; Manuel Feria; Antonio Salinas-Martín; Luis Pedro Martínez-Castillo; José Javier Martín-Ortega
Journal:  Cancer       Date:  2004-12-15       Impact factor: 6.860

6.  Pain, sedation and morphine metabolism in cancer patients during long-term treatment with sustained-release morphine.

Authors:  G Andersen; N H Jensen; L Christrup; S H Hansen; P Sjøgren
Journal:  Palliat Med       Date:  2002-03       Impact factor: 4.762

7.  Dextroamphetamine with morphine for the treatment of postoperative pain.

Authors:  W H Forrest; B W Brown; C R Brown; R Defalque; M Gold; H E Gordon; K E James; J Katz; D L Mahler; P Schroff; G Teutsch
Journal:  N Engl J Med       Date:  1977-03-31       Impact factor: 91.245

8.  The role of methadone in the treatment of moderate to severe cancer pain.

Authors:  Lauren Shaiova
Journal:  Support Cancer Ther       Date:  2005-04-01

Review 9.  Caffeine, fatigue, and cognition.

Authors:  Monicque M Lorist; Mattie Tops
Journal:  Brain Cogn       Date:  2003-10       Impact factor: 2.310

10.  The effect of donepezil on sedation and other symptoms in patients receiving opioids for cancer pain: a pilot study.

Authors:  Eduardo Bruera; Florian Strasser; Loren Shen; J Lynn Palmer; Jie Willey; Larry C Driver; Allen W Burton
Journal:  J Pain Symptom Manage       Date:  2003-11       Impact factor: 3.612

View more
  1 in total

1.  3D microelectrode cluster and stimulation paradigm yield powerful analgesia without noticeable adverse effects.

Authors:  Matilde Forni; Palmi Thor Thorbergsson; Jonas Thelin; Jens Schouenborg
Journal:  Sci Adv       Date:  2021-10-08       Impact factor: 14.136

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.